Inclisirán as an alternative treatment for Hypercholesterolemia
2021 ◽
Vol 12
(3)
◽
pp. 517-521
Keyword(s):
Hypercholesterolemia (CH) is defined as the elevation of serum cholesterol levels, especially low-density lipoprotein (LDL) cholesterol, which is considered to be one of the most relevant risk factors for triggering cardiovascular disease, for This is vitally important to start treatment, there are several highly useful pharmacological groups for lipid-lowering therapy, among them we highlight the PCSK9 inhibitors, among the molecules that are part of this group we find inclisirán, this being a structure that promises a lot in regarding the management of hypercholesterolemia.
1998 ◽
Vol 46
(9)
◽
pp. 1128-1131
◽
2020 ◽
Vol 41
(40)
◽
pp. 3900-3909
◽
2014 ◽
Vol 233
(1)
◽
pp. 206-210
◽
2018 ◽
Vol 17
(6)
◽
pp. 563-570
◽